Hydrogel-Based Drug Delivery Nanosystems for the Treatment of Brain Tumors

Detalhes bibliográficos
Autor(a) principal: Basso, João
Data de Publicação: 2018
Outros Autores: Miranda, Ana, Nunes, Sandra, Cova, Tânia, Sousa, João, Vitorino, Carla, Pais, Alberto
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10316/107658
https://doi.org/10.3390/gels4030062
Resumo: Chemotherapy is commonly associated with limited effectiveness and unwanted side effects in normal cells and tissues, due to the lack of specificity of therapeutic agents to cancer cells when systemically administered. In brain tumors, the existence of both physiological barriers that protect tumor cells and complex resistance mechanisms to anticancer drugs are additional obstacles that hamper a successful course of chemotherapy, thus resulting in high treatment failure rates. Several potential surrogate therapies have been developed so far. In this context, hydrogel-based systems incorporating nanostructured drug delivery systems (DDS) and hydrogel nanoparticles, also denoted nanogels, have arisen as a more effective and safer strategy than conventional chemotherapeutic regimens. The former, as a local delivery approach, have the ability to confine the release of anticancer drugs near tumor cells over a long period of time, without compromising healthy cells and tissues. Yet, the latter may be systemically administered and provide both loading and targeting properties in their own framework, thus identifying and efficiently killing tumor cells. Overall, this review focuses on the application of hydrogel matrices containing nanostructured DDS and hydrogel nanoparticles as potential and promising strategies for the treatment and diagnosis of glioblastoma and other types of brain cancer. Some aspects pertaining to computational studies are finally addressed.
id RCAP_b6513a3581028364d705ee10109cfa09
oai_identifier_str oai:estudogeral.uc.pt:10316/107658
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Hydrogel-Based Drug Delivery Nanosystems for the Treatment of Brain Tumorshydrogelnanostructured drug delivery systemhydrogel nanoparticlesglioblastomadrug deliverylocal treatmentChemotherapy is commonly associated with limited effectiveness and unwanted side effects in normal cells and tissues, due to the lack of specificity of therapeutic agents to cancer cells when systemically administered. In brain tumors, the existence of both physiological barriers that protect tumor cells and complex resistance mechanisms to anticancer drugs are additional obstacles that hamper a successful course of chemotherapy, thus resulting in high treatment failure rates. Several potential surrogate therapies have been developed so far. In this context, hydrogel-based systems incorporating nanostructured drug delivery systems (DDS) and hydrogel nanoparticles, also denoted nanogels, have arisen as a more effective and safer strategy than conventional chemotherapeutic regimens. The former, as a local delivery approach, have the ability to confine the release of anticancer drugs near tumor cells over a long period of time, without compromising healthy cells and tissues. Yet, the latter may be systemically administered and provide both loading and targeting properties in their own framework, thus identifying and efficiently killing tumor cells. Overall, this review focuses on the application of hydrogel matrices containing nanostructured DDS and hydrogel nanoparticles as potential and promising strategies for the treatment and diagnosis of glioblastoma and other types of brain cancer. Some aspects pertaining to computational studies are finally addressed.MDPI2018-07-19info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articlehttp://hdl.handle.net/10316/107658http://hdl.handle.net/10316/107658https://doi.org/10.3390/gels4030062eng2310-2861Basso, JoãoMiranda, AnaNunes, SandraCova, TâniaSousa, JoãoVitorino, CarlaPais, Albertoinfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-07-26T09:44:45Zoai:estudogeral.uc.pt:10316/107658Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T21:23:59.181003Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Hydrogel-Based Drug Delivery Nanosystems for the Treatment of Brain Tumors
title Hydrogel-Based Drug Delivery Nanosystems for the Treatment of Brain Tumors
spellingShingle Hydrogel-Based Drug Delivery Nanosystems for the Treatment of Brain Tumors
Basso, João
hydrogel
nanostructured drug delivery system
hydrogel nanoparticles
glioblastoma
drug delivery
local treatment
title_short Hydrogel-Based Drug Delivery Nanosystems for the Treatment of Brain Tumors
title_full Hydrogel-Based Drug Delivery Nanosystems for the Treatment of Brain Tumors
title_fullStr Hydrogel-Based Drug Delivery Nanosystems for the Treatment of Brain Tumors
title_full_unstemmed Hydrogel-Based Drug Delivery Nanosystems for the Treatment of Brain Tumors
title_sort Hydrogel-Based Drug Delivery Nanosystems for the Treatment of Brain Tumors
author Basso, João
author_facet Basso, João
Miranda, Ana
Nunes, Sandra
Cova, Tânia
Sousa, João
Vitorino, Carla
Pais, Alberto
author_role author
author2 Miranda, Ana
Nunes, Sandra
Cova, Tânia
Sousa, João
Vitorino, Carla
Pais, Alberto
author2_role author
author
author
author
author
author
dc.contributor.author.fl_str_mv Basso, João
Miranda, Ana
Nunes, Sandra
Cova, Tânia
Sousa, João
Vitorino, Carla
Pais, Alberto
dc.subject.por.fl_str_mv hydrogel
nanostructured drug delivery system
hydrogel nanoparticles
glioblastoma
drug delivery
local treatment
topic hydrogel
nanostructured drug delivery system
hydrogel nanoparticles
glioblastoma
drug delivery
local treatment
description Chemotherapy is commonly associated with limited effectiveness and unwanted side effects in normal cells and tissues, due to the lack of specificity of therapeutic agents to cancer cells when systemically administered. In brain tumors, the existence of both physiological barriers that protect tumor cells and complex resistance mechanisms to anticancer drugs are additional obstacles that hamper a successful course of chemotherapy, thus resulting in high treatment failure rates. Several potential surrogate therapies have been developed so far. In this context, hydrogel-based systems incorporating nanostructured drug delivery systems (DDS) and hydrogel nanoparticles, also denoted nanogels, have arisen as a more effective and safer strategy than conventional chemotherapeutic regimens. The former, as a local delivery approach, have the ability to confine the release of anticancer drugs near tumor cells over a long period of time, without compromising healthy cells and tissues. Yet, the latter may be systemically administered and provide both loading and targeting properties in their own framework, thus identifying and efficiently killing tumor cells. Overall, this review focuses on the application of hydrogel matrices containing nanostructured DDS and hydrogel nanoparticles as potential and promising strategies for the treatment and diagnosis of glioblastoma and other types of brain cancer. Some aspects pertaining to computational studies are finally addressed.
publishDate 2018
dc.date.none.fl_str_mv 2018-07-19
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10316/107658
http://hdl.handle.net/10316/107658
https://doi.org/10.3390/gels4030062
url http://hdl.handle.net/10316/107658
https://doi.org/10.3390/gels4030062
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 2310-2861
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv MDPI
publisher.none.fl_str_mv MDPI
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799134125816283136